Discovery of thienoimidazole-based HCV NS5A genotype 1a and 1b inhibitors

被引：0

作者：

Giroux, Simon ^{[1
]}

Xu, Jinwang ^{[1
]}

Reddy, T. Jagadeeswar ^{[2
]}

Morris, Mark ^{[1
]}

Cottrell, Kevin M. ^{[1
]}

Cadilhac, Caroline ^{[2
]}

Henderson, James A. ^{[1
]}

Nicolas, Olivier ^{[3
]}

Bilimoria, Darius ^{[3
]}

Mani, Nagraj ^{[4
]}

Ewing, Nigel ^{[5
]}

Shawgo, Rebecca ^{[5
]}

L'Heureux, Lucille ^{[3
]}

Selliah, Subajini ^{[3
]}

Grillot, Anne-Laure ^{[1
]}

Bennani, Youssef L. ^{[2
]}

Maxwell, John P. ^{[1
]}

机构：

[1] Vertex Pharmaceut, Med Chem, Boston, MA 02210 USA

[2] Vertex Pharmaceut Canada Inc, Med Chem, Laval, PQ H7V 4A7, Canada

[3] Vertex Pharmaceut Canada Inc, Biol, Laval, PQ H7V 4A7, Canada

[4] Vertex Pharmaceut, Biol, Boston, MA 02210 USA

[5] Vertex Pharmaceut, Drug Metab & Pharmacokinet, Boston, MA 02210 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

79-MEDI

引用

页数：1

共 50 条

[1] Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors
Giroux, Simon
Xu, Jinwang
Reddy, T. Jagadeeswar
Morris, Mark
Cottrell, Kevin M.
Cadilhac, Caroline
Henderson, James A.
Nicolas, Oliver
Bilimoria, Darius
Denis, Francois
Mani, Nagraj
Ewing, Nigel
Shawgo, Rebecca
L'Heureux, Lucille
Selliah, Subajini
Chan, Laval
Chauret, Nathalie
Berlioz-Seux, Francoise
Namchuk, Mark N.
Grillot, Anne-Laure
Bennani, Youssef L.
Das, Sanjoy K.
Maxwell, John P.
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (03): : 240 - 243
[2] Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: Non-symmetric inhibitors with potent activity against genotype 1a and 1b
Giroux, Simon
Bilimoria, Darius
Cadilhac, Caroline
Cottrell, Kevin M.
Denis, Francois
Dietrich, Evelyne
Ewing, Nigel
Henderson, James A.
L'Heureux, Lucille
Mani, Nagraj
Morris, Mark
Nicolas, Olivier
Reddy, T. Jagadeeswar
Selliah, Subajini
Shawgo, Rebecca S.
Xu, Jinwang
Chauret, Nathalie
Berlioz-Seux, Francoise
Chan, Laval C.
Das, Sanjoy K.
Grillot, Anne-Laure
Bennani, Youssef L.
Maxwell, John P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 940 - 943
[3] Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-Symmetric inhibitors with diyne and biphenyl linkers
Giroux, Simon
Bilimoria, Darius
Cadilhac, Caroline
Cottrell, Kevin M.
Denis, Francois
Dietrich, Evelyne
Ewing, Nigel
Henderson, James A.
L'Heureux, Lucille
Mani, Nagraj
Morris, Mark
Nicolas, Olivier
Reddy, T. Jagadeeswar
Selliah, Subajini
Shawgo, Rebecca S.
Xu, Jinwang
Chauret, Nathalie
Berlioz-Seux, Francoise
Chan, Laval C.
Das, Sanjoy K.
Grillot, Anne-Laure
Bennani, Youssef L.
Maxwell, John P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 936 - 939
[4] HCV NS5A replication complex inhibitors: Effects of substituted pyrrolidines in balancing genotype 1a/1b potency
Henderson, James A.
Liu, Bingcan
Giroux, Simon
Reddy, T. Jagadeeswar
Bubenik, Monica
Cadilhac, Caroline
Vaillancourt, Louis
Falardeau, Guy
Poisson, Carl
Pereira, Oswy
Cottrell, Kevin M.
Morris, Mark
Nicolas, Olivier
Bilimoria, Darius
Mani, Nagraj
Ewing, Nigel
Shawgo, Rebecca
L'Heureux, Lucille
Selliah, Subajini
Grillot, Anne-Laure
Bennani, Youssef L.
Maxwell, John P.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[5] HCV NS5A mutations in Europeans infected by genotype 1b
Magrin, S
Fabiano, C
Gianguzza, F
Cutrera, M
Alaimo, G
Pagliaro, L
GASTROENTEROLOGY, 1998, 115 (01) : 244 - 245
[6] Benzimidazole-containing HCV NS5A inhibitors: Effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency
Henderson, James A.
Bilimoria, Darius
Bubenik, Monica
Cadilhac, Caroline
Cottrell, Kevin M.
Dietrich, Evelyne
Denis, Francois
Ewing, Nigel
Falardeau, Guy
Giroux, Simon
Grey, Ronald, Jr.
L'Heureux, Lucille
Liu, Bingcan
Mani, Nagraj
Morris, Mark
Nicolas, Olivier
Pereira, Oswy Z.
Poisson, Carl
Rao, B. Govinda
Reddy, T. Jagadeeswar
Selliah, Subajini
Shawgo, Rebecca S.
Vaillancourt, Louis
Wang, Jian
Yannopoulos, Constantin G.
Chauret, Nathalie
Berlioz-Seux, Francoise
Chan, Laval C.
Das, Sanjoy K.
Grillot, Anne-Laure
Bennani, Youssef L.
Maxwell, John P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 944 - 947
[7] Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia
Papaluca, T.
O'Keefe, J.
Bowden, S.
Doyle, J. S.
Stoove, M.
Hellard, M.
Thompson, A. J.
JOURNAL OF CLINICAL VIROLOGY, 2019, 120 : 84 - 87
[8] Hepatitis C virus NS5A polymorphisms in patients with HCV genotype 1B
Shimizu, Yuko
Hayashi, Kazuhiko
Mori, Hiroshi
Toriyama, Kazuhiro
Yoshizaki, Michiyo
Furune, Satoshi
Takenaka, Hiroyuki
Hayashi, Takao
Matuura, Tetuo
Kuroiwa, Masanori
Morita, Keiichi
Ishigami, Masatoshi
Goto, Hidemi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 203 - 203
[9] Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
Hofgartner, WT
Polyak, SJ
Sullivan, DG
Carithers, RL
Gretch, DR
JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (02) : 118 - 126
[10] The incidence of resistance-associated variants to NS5A in HCV subtypes 1a and 1b in Taiwan
Tsai, Ming-Chao
Hung, Chao-Hung
Lu, Sheng-Nan
Wang, Jing-Houng
Chen, Chien-Hung
Kee, Kwong-Ming
Chang, Kuo-Chin
Chao, Tsai-Ling
Hu, Tsung-Hui
BIOMEDICAL JOURNAL, 2021, 44 (06) : S126 - S131

← 1 2 3 4 5 →